Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
orward-looking statements that involve certain risks anduncertainties including but not limited to risks associated with theuncertainty of future financial results additional financing requirementsdevelopment of new products government approval processes the impact ofcompetitive products or pricing technological changes the effect ofeconomic conditions and other uncertainties detailed i
Date:2/7/2008
orward-looking statements that involve certain risks and
uncertainties including but not limited to risks associated with the
uncertainty of future financial results, additional financing requirements,
development of new products, government approval processes, the impact of
competitive products or pricing, technological changes, the effect of
economic conditions and other uncertainties detailed in the Company's
filings with the Securities and Exchange Commission.
'/>"/>SOURCE Tianyin Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board2.
Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference3.
Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference4.
Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation5.
Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference6.
Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products7.
A New, Unique and Unrivalled Rat/Mouse PINP Assay for Pharmaceutical, Clinical and Academic Research Organizations.8.
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference to Webcast Alexzas Corporate Presentation9.
Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference10.
Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference11.
Angiotech to participate in Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference